Cartalax (20 mg Vial) Dosage Protocol
Cartalax is a synthetic peptide bioregulator targeting cartilage tissue, studied in Russian protocols for joint and cartilage health.
⚡ Quickstart Highlights
Dosing & Reconstitution Guide
Educational framework for reconstitution and daily dosing
Standard / Gradual Approach (3 mL = ~6.67 mg/mL)
Route & Frequency: Subcutaneous, once daily. Evidence note: Specific human RCT posology for SC Cartalax is limited; this schedule references preclinical fibroblast/chondrocyte studies and general SC technique guidance.
| Week/Phase | Daily Dose (mcg / mg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 2,000 mcg (2.0 mg) | 30 units (0.30 mL) |
| Weeks 3–4 | 3,000 mcg (3.0 mg) | 45 units (0.45 mL) |
| Weeks 5–8 | 4,000 mcg (4.0 mg) | 60 units (0.60 mL) |
| Weeks 9–12 | 5,000 mcg (5.0 mg) | 75 units (0.75 mL) |
This schedule uses the largest practical dilution (3.0 mL) to keep per‑injection volumes within typical SC tolerability parameters (≤~1.0 mL per site).
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Insert needle through the stopper; let the diluent run slowly down the vial wall to avoid foaming.
- Gently swirl or roll until fully dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Supplies Needed
Plan based on an 8–16 week daily protocol with gradual titration (average ~3.5 mg/day).
| Item | Quantity |
|---|---|
| Peptide Vials (Cartalax, 20 mg each) | 8 weeks: approximately 10 vials required 12 weeks: approximately 15 vials required 16 weeks: approximately 20 vials required |
| Insulin Syringes (U‑100) | Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes |
| Bacteriostatic Water (10 mL bottles) | 8 weeks (10 vials): 30 mL — 3 bottles required (10 mL each) 12 weeks (15 vials): 45 mL — 5 bottles required (10 mL each) 16 weeks (20 vials): 60 mL — 6 bottles required (10 mL each) |
| Alcohol Swabs | Per week: 14 swabs (2/day) 8 weeks: 112 swabs — 2 boxes required (100 swabs each) 12 weeks: 168 swabs — 2 boxes required (100 swabs each) 16 weeks: 224 swabs — 3 boxes required (100 swabs each) |
Protocol Overview
The hypothesized gene-expression mechanism produces effects that persist months after the cycle ends, supporting the cycled rather than continuous approach.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | −20°C (−4°F) | Up to 24 months, dry & dark |
| Reconstituted | 2–8°C (35–46°F) | Up to 30 days, protect from light |
Important Notes
How This Works
Cartalax is a Khavinson-class peptide bioregulator hypothesized to support chondrocyte function and cartilage matrix maintenance.
Potential Benefits & Side Effects
Potential Benefits
- Joint and cartilage support in Russian clinical protocols.
- Pairs with BPC-157 in some recovery stacks.
Side Effect Profile
- Generally well-tolerated.
- Mild injection-site reactions.
Lifestyle Factors
- Adequate collagen-supportive nutrients (vitamin C, copper).
- Low-impact exercise during recovery.
Injection Technique
- Subcutaneous, rotate sites.